Benzimidazole derivatives

Details Benzimidazole derivatives Benzimidazole derivatives

2005-01-13

2011-10-04

Skowronek, Karlheinz R (Department: 1613)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S310100, C548S310700

Reexamination Certificate

active

08030497

ABSTRACT:
A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof:wherein R1-R7 are as disclosed in the specification.

REFERENCES:
patent: 2500487 (1950-03-01), Craig
patent: 3080282 (1963-03-01), Shunk
patent: 3162574 (1964-12-01), Forsyth
patent: 3294542 (1966-12-01), Sus et al.
patent: 5626875 (1997-05-01), Ballester Rodes et al.
patent: 6184235 (2001-02-01), Connor et al.
patent: 6696437 (2004-02-01), Lubisch et al.
patent: 6855714 (2005-02-01), Blume et al.
patent: 2004/0170689 (2004-09-01), Odink et al.
patent: 03/099776 (2003-12-01), None
patent: 03/099814 (2003-12-01), None
Andre Mauricio de Oliveira, et al, QSAR and Molecular Modelling Studies on B-DNA Recognition of Minor Groove Binders, 38 Eur. J. Med. Chem. 141 (2003).
George Patani & Edmond LaVoie, Bioisosterism: A Rational Approach in Drug Design, 96 Chem. Rev. 3147 (1996).
Gowen M et al., “Antagonizing the Parathyroid Calcium Receptor Stimulates Parathyroid Hormone Secretion and Bone Formation in Osteopenic Rats”, Journal of Clinical Investigation, NY, vol. 105, No. 11, pp. 1595-1604, (2000).

Affiliated with

Also associated with

Rating

Benzimidazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4281548